PDF herunterladen
Open Access
CC BY 4.0 · Journal of Health and Allied Sciences NU 2023; 13(04): 575-580
DOI: 10.1055/s-0043-1762580
Original Article

Comparison of Estrogen Receptor Status and Ki-67 Index in Core Needle Biopsy and Resected Specimen of Breast Carcinoma

Autoren

  • Geoffrey Sundar E. 

    1   Dr. Somervell Memorial CSI Medical College and Hospital, Karakonam, Thiruvananthapuram, Kerala, India

  • Kishan Prasad HL

    2   Department of Pathology, K. S. Hegde Medical Academy, NITTE (Deemed to be University), Deralakatte, Mangaluru, Karnataka, India

  • Jayaprakash Shetty K.

    2   Department of Pathology, K. S. Hegde Medical Academy, NITTE (Deemed to be University), Deralakatte, Mangaluru, Karnataka, India

  • Chandrika Rao 

    2   Department of Pathology, K. S. Hegde Medical Academy, NITTE (Deemed to be University), Deralakatte, Mangaluru, Karnataka, India

  • Apoorva K. 

    2   Department of Pathology, K. S. Hegde Medical Academy, NITTE (Deemed to be University), Deralakatte, Mangaluru, Karnataka, India

Funding None.
Weitere Informationen
Auch verfügbar auf
  Lizenzen und Reprints

Abstract

Background and Objectives The status of estrogen receptor (ER), progesterone receptor (PR), human epidermal growth factor receptor 2 (HER2), and Ki-67 expression in core needle biopsy and excision specimens has concurrent results, but many show discordance. However, only a few studies on the subject are available in India. Therefore, this study aims to compare the ER and Ki-67 expression status in core needle biopsy and excision specimens of breast carcinoma.

Materials and Methods In this cross-sectional analytical study, 50 breast carcinoma cases were histopathologically examined for ER and Ki-67 expression in both core needle biopsy and excision specimen. The interpreter was blinded for the evaluation of ER and Ki-67 expression index and the data obtained were analyzed using SPSS version 27.

Results The average age of the participants was 50 years and breast lump was the most common presenting complaint in all the cases. The concordance rate of histological typing between core needle biopsy and excision specimens was 96%, and the majority were invasive ductal carcinoma (60%) and not otherwise specified (48%) having Nottingham histologic grade 3 (46%). The concordance rate between core needle biopsy and excision specimen for ER and Ki-67 expression was 86% (n = 43) and 54% (n = 27), respectively. Most of the cases were found to be luminal A type (38%). Additionally, the sensitivity, specificity, positive predictive value, and negative predictive value of ER between core needle biopsy and excision specimen were 78.79, 100, 100, and 70.83%, respectively; however, these were 44, 64, 55, and 53.33%, respectively, for Ki-67.

Conclusion Although the concordance of the ER status between core needle biopsy and excision specimen was substantial, the discordance rate of Ki-67 was found to be high. Hence, relying solely on core needle biopsy for critical decision-making is inadvisable; however, core needle biopsy can be used as an initial procedure to examine histology and receptor status, Therefore, it is better to reconsider performing immunohistochemistry for the excision specimen, more importantly in ER-negative cases, to benefit the patient with targeted therapy.

Keywords

breast carcinoma - core needle biopsy - estrogen receptor - excision specimen - immunohistochemistry - Ki-67

Supplementary Material



Publikationsverlauf

Artikel online veröffentlicht:
14. April 2023

© 2023. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/)

Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India